414 a Fitst-In-Human Study of BLZ-100 (Tozuleristide) Demonstrates Tolerability and Fluorescence Contrast in Skin Cancer
Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.421
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2018
Authors
Publisher
Elsevier BV